Security Interest in Patent Licenses to Gtc Biotherapeutics, Inc.

Recorded: 2008-12-22 Received: 2008-12-22 Pages: 37

Assignor

GTC BIOTHERAPEUTICS, INC.

Executed: 2008-12-22

Assignee

LFB BIOTECHNOLOGIES S.A.S.U

3, AVENUE DES TROPIQUES, LES ULIS, COURTABOEUF, FRX, 91940, FRANCE

Covered Properties (8)

Treatment And Prophylaxis With 4-1BB-Binding Agents

Application: 12/269,462 →

Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use

Application: 11/586,431 →

Method for the crystallization of human serum albumin

Application: 11/378,727 →

Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants

Application: 11/057,522 →

Enhancement of Immune Responses by 4-1BB-Binding Agents

Application: 10/492,056 →

Treatment of lung disorders

Application: 10/396,855 →

Method for the Crystallization of Human Serum Albumin

Application: 10/300,233 →

Production of Membrane Proteins in the Milk of Transgenic Mammals

Application: 10/185,269 →